LCMT1-AS2

Across TCGA pan-cancer cohorts, LCMT1-AS2 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LCMT1-AS2 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LCMT1-AS2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LCMT1-AS2 expression acts as an unfavorable survival marker, although some lineages such as ESCA and BRCA show a favorable association.

COAD, THCA, and CESC are the cancer types where LCMT1-AS2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	II,III,IV	0.793	0.901	.001	57	view →
THCA	OS	Quartile	II,III,IV	0.622	1.000	.002	46	view →
CESC	OS	Quartile	All	0.705	0.851	.009	38	view →
LIHC	DFS	Quartile	All	0.256	0.511	.001	21	view →
ESCA	OS	Median	III,IV	0.633	0.324	.005	20	view →
BRCA	DFS	Tertile	III,IV	0.850	0.711	.012	19	view →
BLCA	DFS	Tertile	All	0.430	0.686	.003	18	view →
LUSC	OS	Median	IV	0.057	0.786	.017	18	view →
LAML	DFS	Median	All	0.602	0.329	.008	18	view →
READ	OS	Tertile	II,III,IV	1.000	0.436	.011	16	view →
KICH	OS	Tertile	III,IV	1.000	0.437	.012	10	view →
ACC	DFS	Median	III,IV	0.425	0.112	.016	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

LCMT1-AS2–COAD (OS)

Open the COAD breakdown →